[1]杨小龙,陆欢△,朱超,等.骨复生胶囊联合髓芯减压自体髂骨植骨治疗早期股骨头坏死的临床研究[J].中国中医骨伤科杂志,2024,32(01):20-24+30.[doi:10.20085/j.cnki.issn1005-0205.240104]
　YANG Xiaolong,LU Huan,ZHU Chao,et al.Clinical Observation on Early Osteonecrosis of the Femoral Head Treated by Core Decompression and Autogenous Iliac Bone Grafting Combined with Gufusheng Capsule[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2024,32(01):20-24+30.[doi:10.20085/j.cnki.issn1005-0205.240104]
点击复制

骨复生胶囊联合髓芯减压自体髂骨植骨治疗早期股骨头坏死的临床研究()
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第32卷
期数:
2024年01期
页码:
20-24+30
栏目:
临床研究
出版日期:
2024-01-15

文章信息/Info

Title:
Clinical Observation on Early Osteonecrosis of the Femoral Head Treated by Core Decompression and Autogenous Iliac Bone Grafting Combined with Gufusheng Capsule
文章编号:
1005-0205(2024)01-0020-05
作者:
杨小龙1; 陆欢1△; 朱超2; 范柯君1; 刘海瑞1
1解放军联勤保障部队第九〇二医院(安徽 蚌埠,233015) 2陕西中医药大学附属医院
Author(s):
YANG Xiaolong1; LU Huan1△; ZHU Chao2; FAN Kejun1; LIU Hairui1
1Hospital 902 of PLA,Bengbu 233015,Anhui China; 2Affiliated Hospital of Shaanxi University of Chinese Medicine,Xianyang 712000,Shaanxi China.
关键词:
股骨头坏死;  髓芯减压术;  自体髂骨植骨;  骨复生胶囊
Keywords:
osteonecrosis of the femoral head;  core decompression;  autogenous iliac bone graft;  Gufusheng capsule
分类号:
R681.8
DOI:
10.20085/j.cnki.issn1005-0205.240104
文献标志码:
A
摘要:
目的:观察骨复生胶囊联合髓芯减压自体髂骨植骨术治疗早期股骨头坏死的临床效果。方法:选取2014年1月至2020年6月诊断为股骨头坏死(ARCOⅡA～ⅢA期)的住院患者70例(83髋),按照随机数字表法分为两组,每组35例,对照组采用髓芯减压自体髂骨植骨术治疗,观察组在其基础上口服骨复生胶囊6个月,观察两组在治疗12个月后的视觉模拟量表(VAS)评分、髋关节功能日本骨科协会(JOA)评分、国际骨循环学会(ARCO)分期影像学表现变化。结果:治疗12个月后两组患者VAS评分、髋关节功能JOA评分均有明显改善,差异有统计学意义(P<0.05),且观察组优于对照组,差异有统计学意义(P<0.05); 两组患者ARCO分期影像学表现也均有改善,差异有统计学意义(P<0.05),且观察组改善明显优于对照组,差异有统计学意义(P<0.05)。结论:骨复生胶囊联合髓芯减压自体髂骨植骨术治疗早期股骨头坏死能显著提高髋关节功能评分,缓解髋关节疼痛,改善影像学特征,比单纯髓芯减压植骨术具有更好的临床效果。
Abstract:
Objective:To observe the efficiency of Gufusheng capsule combined with core decompression and autogenous iliac bone grafting at the femoral head-neck junction on the treatment of osteonecrosis of the femoral head(ONFH).Methods:70 cases of patients(83 hips)diagnosed with femoral head necrosis(ARCO ⅡA-ⅢA stage)were selected from January 2014 to June 2020.They were divided into two groups according to the random number table method,with 35 cases in each group.The control group was treated with only core decompression and autogenous bone grafting.The observation group received additionally treated with Gufusheng capsule based on the treatment of the control group.The pain improvements of the 2 groups before and after operation were assessed by the visual analogue scale(VAS).The functions of hip joint in 2 groups before and after operation were evaluated by Japanese orthopaedic association(JOA)score.And imaging methods was used to observed the morphological changes of the femoral head.Results:The post-operative VAS scores of the 2 groups decreased significantly(P<0.05)comparing with the pre-operative scores.The VAS score of the observation group decreased more significantly,and the difference between the two groups was statistically significant(P<0.05).The post-operative JOA scores increased significantly(P<0.05)comparing with the pre-operative scores.The JOA scores in the observation group were slightly higher than those in the control group with statistical significance(P<0.05).The post-operative imaging performance of the femoral head in the 2 groups was significantly improved(P<0.05),and the difference between the control group and the observation group was statistically significant(P<0.05).Conclusion:The therapy of Gufusheng capsule combined with core decompression and autogenous iliac bone grafting at the femoral head-neck junction for patients with osteonecrosis of the femoral head can effectively improve the functions of hip joint,alleviate the clinical symptoms,improve the imaging performance of the femoral head,and has significant therapeutic efficacy.The recent clinical efficacy of Gufusheng capsule combined with core decompression and autogenous iliac bone grafting is superior to core decompression and autogenous iliac bone grafting.

参考文献/References:

[1] HERNDON J H,AUFRANC O E.Avascular necrosis of the femoral head in the adult:a review of its incidence in a variety of conditions[J].Clin Orthop,1972,86:43-62.
[2] MONT M A,CHERIAN J J,SIERRA R J,et al.Nontraumatic osteonecrosis of the femoral head:where do we stand today? A ten-year update[J].J Bone Joint Surg:Am,2015,97(19):1604-1627.
[3] MOYA-ANGELER J,GIANAKOS A L,VILLA J C,et al.Current concepts on osteonecrosis of the femoral head[J].World J Orthop,2015,6(8):590-601.
[4] 李永志,董博,欧国峰,等.骨复生对激素性股骨头坏死大鼠骨组织中OPG及RANK表达的影响[J].中国中医骨伤科杂志,2018,26(11):1-6.
[5] 中华医学会骨科分会显微修复学组,中国修复重建外科专业委员会骨缺损及骨坏死学组.成人股骨头坏死诊疗标准专家共识(2012年版)[J].中华关节外科杂志(电子版),2012,6(3):89-92.
[6] GARDENIERS J W.ARCO interational stage of osteonecrosis[J].ARCO Newletter,1993,5:79-82.
[7] 杨小龙,王平均,连文文,等.自体植骨髂嵴前部取骨的几种方式比较[J].淮海医药,2012,30(5):390-391.
[8] 胡永成,邱贵兴,马信龙,等.骨科疾病疗效评价标准[M].北京:人民卫生出版社,2012:129-130.
[9] ZHAO D W,HU Y C.Chinese experts,consensus on the diagnosis and treatment of osteonecrosis of the femoral head in adults[J].Orthop Surg,2012,4(3):125-130.
[10] 贾敏,江蓉星,肖鹏.浅谈股骨头坏死的中医病因病机[J].内蒙古中医药,2013,32(24):135-136.
[11] 刘芳,姚洁,董博.针刀疗法结合骨复生胶囊治疗早中期股骨头缺血性坏死82例[J].现代中医药,2017,37(5):53-55.
[12] ISSA K,PIVEC R,KAPPADIA B H,et al.Osteonecrosis of the femoral head:the total hip replacement solution[J].Bone Joint J,2013,95B(11 Suppl A):46-50.
[13] 谢林,马俊,邓立庆,等.经皮头颈开窗人工骨支撑植骨术治疗早期股骨头坏死[J].中国矫形外科杂志,2017,25(9):769-774.
[14] 闫韵飞,陆维举,褚立涛,等.微创股骨头清创植骨术治疗股骨头坏死[J].中国骨与关节损伤杂志,2017,32(10):1009-1011.
[15] 王亚国,王官林,董博,等.骨复生治疗股骨头坏死的临床疗效及其对血液流变学的影响[J].陕西中医药大学学报,2020,43(5):70-75.
[16] 王国毓,姚永东,杨毓华,等.骨复生对激素性股骨头缺血坏死家兔血液流变学的影响[J].中医正骨,2001,13(4):11-12.
[17] 李毅,吕正茂,刘德玉,等.骨复生胶囊对激素性股骨头缺血坏死家兔一氧化氮及纤溶活性的影响[J].中国中医骨伤科杂志,2002,10(2):30-33.
[18] 胡学元,李国瑛.中西医结合治疗早期股骨头坏死的临床体会[J].中国中医骨伤科杂志,2013,21(6):53-54.

备注/Memo

备注/Memo:
基金项目:国家中医药管理局科研专项(JDZX2015280)
△通信作者 E-mail:344670611@qq.com
更新日期/Last Update: 2024-01-15